Saturday, July 11, 2026

pharma · Sepsis · Tumor, Solid

Sichuan Kelun Pharmaceutical

Sichuan Kelun Pharmaceutical clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
375 Employees
NMPA registrant Type
Company details
Status
Public
HQ
CN
Employees
375
Programs
4
Drugs
6
Patents
0
Intelligence · Clinical Programs

Sichuan Kelun Pharmaceutical projects

1 ClinicalTrials.gov programs sponsored by Sichuan Kelun Pharmaceutical.

Sichuan Kelun Pharmaceutical has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. SKB103 for injection monotherapy

    Sichuan Provincial People's Hospital

    Advanced Solid Tumors

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Sichuan Kelun Pharmaceutical have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.